Delivery of a Survivin Promoter-Driven Antisense Survivin-Expressing Plasmid DNA as a Cancer Therapeutic: A Proof-Of-Concept Study

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s101209
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Survivin Is a Therapeutic Target in Merkel Cell Carcinoma

Science Translational Medicine
Medicine
2012English

Survivin Promoter Polymorphism (-31 C/G): A Genetic Risk Factor for Oral Cancer

Asian Pacific Journal of Cancer Prevention
2019English

XIAP and Survivin as Therapeutic Targets for Radiation Sensitization in Preclinical Models of Lung Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2004English

HLA-A24 and Survivin: Possibilities in Therapeutic Vaccination Against Cancer

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2006English

Survivin as a Novel Target Protein for Reducing the Proliferation of Cancer Cells (Review)

Biomedical Reports
GeneticsPharmacologyMolecular BiologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2018English

Application of Quantum Dots as Vectors in Targeted Survivin Gene siRNA Delivery

OncoTargets and Therapy
OncologyPharmacology
2013English

High Therapeutic Efficacy of a New Survivin LSP-Cancer Vaccine Containing CD4+ and CD8+ T-Cell Epitopes

Frontiers in Oncology
Cancer ResearchOncology
2018English

ZIC1 Acts a Tumor Suppressor in Breast Cancer by Targeting Survivin

International Journal of Oncology
Cancer ResearchOncology
2018English

Antisense Modulation of RNA Processing as a Therapeutic Approach in Cancer Therapy

Drug Discovery Today: Therapeutic Strategies
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy